Novavax, Inc.
(NASDAQ : NVAX)

( )
NVAX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. 0.00%204.730.0%$1981.02m
NVAXNovavax, Inc. 0.00%110.8278.2%$792.93m
BIIBBiogen, Inc. 0.00%239.301.8%$522.63m
AMGNAmgen, Inc. 0.00%235.361.4%$522.04m
BNTXBioNTech SE 0.00%196.000.0%$501.82m
GILDGilead Sciences, Inc. 0.00%71.771.0%$472.12m
ILMNIllumina, Inc. 0.00%405.143.3%$406.87m
REGNRegeneron Pharmaceuticals, Inc. 0.00%615.242.7%$388.21m
VRTXVertex Pharmaceuticals, Inc. 0.00%234.061.9%$331.63m
SNSSSunesis Pharmaceuticals, Inc. 0.00%3.170.7%$221.59m
EXASEXACT Sciences Corp. 0.00%78.4317.9%$151.61m
ALNYAlnylam Pharmaceuticals, Inc. 0.00%148.508.2%$151.18m
ARNAArena Pharmaceuticals, Inc. 0.00%92.6513.7%$144.29m
INCYIncyte Corp. 0.00%74.882.4%$128.10m
BBIOBridgeBio Pharma, Inc. 0.00%12.750.0%$115.66m

Company Profile

Novavax, Inc. focuses on the discovery, development and commercialization of vaccines to prevent infectious diseases. It provides vaccines for COVID-19, seasonal flu, respiratory syncytial virus, Ebola, and Middle East respiratory syndrome. The company was founded in 1987 and is headquartered in Gaithersburg, MD.